Agilent Technologies (A) Capital Expenditures Growth (3y) (2012 - 2026)
Powered by 
Analysis
Agilent Technologies (A) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -6.49% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -0.41% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -5.23% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -7.41% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -7.83% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -2.61% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -13.49% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 60.17% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 7.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -0.41% |
| Apr 30, 2026 | 10.06% |
| Jan 31, 2026 | 6.96% |
| Oct 31, 2025 | 9.93% |
| Jul 31, 2025 | 7.90% |
| Apr 30, 2025 | 21.22% |
| Jan 31, 2025 | 8.95% |
| Oct 31, 2024 | 14.47% |
| Jul 31, 2024 | 19.43% |
| Apr 30, 2024 | 49.22% |
| Jan 31, 2024 | 29.96% |
| Oct 31, 2023 | 45.98% |
| Jul 31, 2023 | 47.97% |
| Apr 30, 2023 | 19.98% |
| Jan 31, 2023 | 30.75% |
| Oct 31, 2022 | 32.64% |
| Jul 31, 2022 | 20.38% |
| Apr 30, 2022 | 17.95% |
| Jan 31, 2022 | 24.36% |
| Oct 31, 2021 | 19.87% |